JP2024515446A5 - - Google Patents

Info

Publication number
JP2024515446A5
JP2024515446A5 JP2023557007A JP2023557007A JP2024515446A5 JP 2024515446 A5 JP2024515446 A5 JP 2024515446A5 JP 2023557007 A JP2023557007 A JP 2023557007A JP 2023557007 A JP2023557007 A JP 2023557007A JP 2024515446 A5 JP2024515446 A5 JP 2024515446A5
Authority
JP
Japan
Prior art keywords
dose inhaler
pressurized
metered
dose
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515446A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021612 external-priority patent/WO2022204328A1/en
Publication of JP2024515446A publication Critical patent/JP2024515446A/ja
Publication of JP2024515446A5 publication Critical patent/JP2024515446A5/ja
Priority to JP2026029334A priority Critical patent/JP2026094267A/ja
Pending legal-status Critical Current

Links

JP2023557007A 2021-03-23 2022-03-23 アナフィラキシーを処置するためのデバイス Pending JP2024515446A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026029334A JP2026094267A (ja) 2021-03-23 2026-02-26 アナフィラキシーを処置するためのデバイス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163165102P 2021-03-23 2021-03-23
US63/165,102 2021-03-23
PCT/US2022/021612 WO2022204328A1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026029334A Division JP2026094267A (ja) 2021-03-23 2026-02-26 アナフィラキシーを処置するためのデバイス

Publications (2)

Publication Number Publication Date
JP2024515446A JP2024515446A (ja) 2024-04-10
JP2024515446A5 true JP2024515446A5 (cg-RX-API-DMAC7.html) 2025-04-18

Family

ID=81307871

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023557007A Pending JP2024515446A (ja) 2021-03-23 2022-03-23 アナフィラキシーを処置するためのデバイス
JP2026029334A Pending JP2026094267A (ja) 2021-03-23 2026-02-26 アナフィラキシーを処置するためのデバイス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026029334A Pending JP2026094267A (ja) 2021-03-23 2026-02-26 アナフィラキシーを処置するためのデバイス

Country Status (20)

Country Link
US (1) US20220331237A1 (cg-RX-API-DMAC7.html)
EP (2) EP4188332B1 (cg-RX-API-DMAC7.html)
JP (2) JP2024515446A (cg-RX-API-DMAC7.html)
KR (1) KR20230165764A (cg-RX-API-DMAC7.html)
CN (1) CN117083054A (cg-RX-API-DMAC7.html)
AU (1) AU2022245300B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023019156A2 (cg-RX-API-DMAC7.html)
CA (1) CA3212189A1 (cg-RX-API-DMAC7.html)
DK (1) DK4188332T3 (cg-RX-API-DMAC7.html)
ES (2) ES3025005T3 (cg-RX-API-DMAC7.html)
FI (1) FI4188332T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20250566T1 (cg-RX-API-DMAC7.html)
HU (1) HUE071185T2 (cg-RX-API-DMAC7.html)
IL (1) IL305534A (cg-RX-API-DMAC7.html)
LT (1) LT4188332T (cg-RX-API-DMAC7.html)
PL (1) PL4188332T3 (cg-RX-API-DMAC7.html)
PT (1) PT4188332T (cg-RX-API-DMAC7.html)
RS (1) RS66787B1 (cg-RX-API-DMAC7.html)
SI (1) SI4188332T1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12514995B2 (en) * 2021-02-15 2026-01-06 Glenmark Pharmaceuticals Limited Metered dose inhalers of fluticasone or an ester thereof
WO2025072756A1 (en) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Device, methods, and uses for treating acute allergic reactions
WO2025170986A1 (en) * 2024-02-06 2025-08-14 Kindeva Drug Delivery L.P. Drug delivery device
US20260007598A1 (en) * 2024-07-05 2026-01-08 Honeywell International Inc. Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients
US12496272B1 (en) * 2024-07-31 2025-12-16 Amphastar Pharmaceuticals, Inc. Stable epinephrine suspension formulation for inhalation with HFO propellant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
AU2004249166B2 (en) * 2003-06-13 2008-10-09 Alkermes, Inc. Low dose pharmaceutical powders for inhalation
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
US8367734B1 (en) * 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
SI2627386T1 (sl) * 2010-10-12 2015-10-30 Ivax Pharmaceuticals Ireland Nosna pršilna naprava
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2014033057A1 (en) * 2012-08-29 2014-03-06 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
ES2791775B2 (es) * 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
WO2019182745A1 (en) * 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations

Similar Documents

Publication Publication Date Title
JP7621220B2 (ja) 疾患の処置のための鼻腔内エピネフリン製剤及び方法
TWI278324B (en) Dry powder for use in the preparation of medicament for the treatment of chronic obstructive pulmonary disease
US7767698B2 (en) Formulation and use thereof
US6284765B1 (en) (+) naloxone and epinephrine combination therapy
CA2487699C (en) A buffered, liquid nicotine composition for pulmonary administration
RU2519344C2 (ru) Применение глюкокортикоидной композиции для лечения тяжелой и неконтролируемой астмы
Barach et al. Inhalation of penicillin aerosol in patients with bronchial asthma, chronic bronchitis, bronchiectasis and lung abscess: preliminary report
US20040235807A1 (en) Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
JP2002104963A (ja) 痛みの治療または予防のための吸入可能なエーロゾル薬剤
WO2013138654A1 (en) Methods of administering high concentrations of nitric oxide
JP2012505262A (ja) Copd及びその他の肺疾患の治療方法
JP2020519628A5 (cg-RX-API-DMAC7.html)
EP2825179A1 (en) Methods of administering high concentrations of nitric oxide
JP2005508963A (ja) 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ
JP2003535130A (ja) ジメチルスルホンの経口投与によるいびきの管理
O’Callaghan et al. The history of inhaled drug therapy
WO2025167739A1 (zh) 化合物在制备预防和/或治疗高原病的药物中的应用
US9737550B2 (en) Treatment of congestion using steroids and adrenergics
Ceriana et al. Use of bronchodilators during non-invasive mechanical ventilation
EP4100089A1 (en) Method, apparatus and kit for treating chronic and long-term nasal congestion
US3050443A (en) Headache remedy containing ammonia
JP2024533453A (ja) 送達デバイスおよび組成物
Cahalin et al. Pulmonary medications
HK40092206A (en) Intranasal epinephrine formulations and methods for the treatment of disease
HK40121592A (en) Intranasal epinephrine formulations and methods for the treatment of disease